Cited by 1,773Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchDiabetes Management and Education

Epidemiology of Diabetes and Diabetes-Related Complications

Open access
Deshpande, Anjali D, Harris-Hayes, Marcie, Schootman, Mario·2008·Physical Therapy

Abstract

In 2005, it was estimated that more than 20 million people in the United States had diabetes. Approximately 30% of these people had undiagnosed cases. Increased risk for diabetes is primarily associated with age, ethnicity, family history of diabetes, smoking, obesity, and physical inactivity. Diabetes-related complications—including cardiovascular disease, kidney disease, neuropathy, blindness, and lower-extremity amputation—are a significant cause of increased morbidity and mortality among people with diabetes, and result in a heavy economic burden on the US health care system. With advances in treatment for diabetes and its associated complications, people with diabetes are living longer with their condition. This longer life span will contribute to further increases in the morbidity associated with diabetes, primarily in elderly people and in minority racial or ethnic groups. In 2050, the number of people in the United States with diagnosed diabetes is estimated to grow to 48.3 million. Results from randomized controlled trials provide evidence that intensive lifestyle interventions can prevent or delay the onset of diabetes in high-risk individuals. In addition, adequate and sustained control of blood sugar levels, blood pressure, and blood lipid levels can prevent or delay the onset of diabetes-related complications in people with diabetes. Effective interventions, at both the individual and population levels, are desperately needed to slow the diabetes epidemic and reduce diabetes-related complications in the United States. This report describes the current diabetes epidemic and the health and economic impact of diabetes complications on individuals and on the health care system. The report also provides suggestions by which the epidemic can be curbed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2522/ptj.20080020

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • More than 35% of individuals with type 2 diabetes are co-diagnosed with ASCVD, HF or CKD.

    “Because of the shared pathophysiological mechanisms underpinning the development of type 2 diabetes and cardiorenal conditions, coupled with the micro- and macrovascular consequences of chronic unmitigated hyperglycaemia, more than 35% of individuals with type 2 diabetes are co-diagnosed with atherosclerotic cardiovascular disease (ASCVD), congestive heart failure (HF) or chronic kidney disease (C”

    From Racial and ethnic disparities in the uptake of SGLT2is and GLP-1RAs among Medicare beneficiaries with type 2 diabetes and heart failure, atherosclerotic cardiovascular disease and chronic kidney disease, 2013–2019 (2025) · cites this paper as [1]

    The Heart Disease and Stroke and Nephropathy (Renal Disease) sections discuss cardiovascular and kidney complications of diabetes, but neither gives the proportion of people with type 2 diabetes co-diagnosed with ASCVD, heart failure, or CKD. Searches for “more than 35%” and the named conditions found no passage establishing that figure. (LLM, conf=0.75)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 11

  1. Benjamin SM, Valdez R, Geiss LS, et al. Es- timated number of adults with prediabetes in the US in 2000: opportunities for preven- tion. Diabetes Care. 2003;26:645-649.
  2. Rewers M, Hamman RF. Risk factors for non-insulin-dependent diabetes. In: Harris MI, Cowie CC, Stern MP, et al, eds. Dia- betes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National In- stitute of Diabetes and Digestive and Kid- ney Diseases; 1995:179 -220. NIH publica- tion 95-1468.
  3. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: Har- ris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:233-257. NIH pub- lication 95-1468.
  4. Boulton AJ, Vinik AI, Arezzo JC, et al. Dia- betic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28:956 -962.
  5. Eaton S, Tesfaye S. Clinical manifestations and measurement of somatic neuropathy. Diabetes Review. 1997;7:312-325.
  6. Slyke MP. Painful peripheral diabetic neu- ropathy: therapeutic approaches. Consult Pharm. 2000;15:544 -555.
  7. Reiber GE, Boyko EJ, Smith DG. Lower extremity foot ulcers and amputation in diabetes. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:409 - 428. NIH publication 95-1468.
  8. Palumbo PJ, Melton LJ III. Peripheral vas- cular disease and diabetes. In: Harris MI, Cowie CC, Stern MP, et al, eds. Diabetes in America. 2nd ed. Bethesda, MD: Na- tional Institutes of Health, National Insti- tute of Diabetes and Digestive and Kidney Diseases; 1995:401-408. NIH publication 95-1468.
  9. Larsson J, Apelqvist J. Towards less ampu- tations in diabetic patients. Acta Orthop Scand. 1995;66:181-192.
  10. Hogan P, Dall T, Nikolov P; American Di- abetes Association. Economic costs of di- abetes in the US in 2002. Diabetes Care. 2003;26:917-932.
  11. Krein SL, Funnell MM, Piette JD. Econom- ics of diabetes mellitus. Nurs Clin North Am. 2006;41:499 -511, v-vi.

Cited by

Sorted by citations

Authors
Deshpande, A. D., Harris-Hayes, M., & Schootman, M.
Affiliations
  • Washington University in St. Louis (US)
  • M Harris-Hayes, PT, DPT, OCS, is Assistant Professor, Program in Physical Therapy, Washington University School of Medicine.
Corresponding author
Deshpande, Anjali D
Venue
Physical Therapy
Published
2008-11-01
Volume
88
Issue
11
Pages
1254-1264
ISSN
  • 0031-9023 (ISSN-L)
  • 1538-6724
OpenAlex
W2165560933
Cited by
1,773
References
87
Citations by year
2026: 86 · 2025: 180 · 2024: 247 · 2023: 219 · 2022: 207 · 2021: 160 · 2020: 119 · 2019: 74 · 2018: 71 · 2017: 76 · 2016: 58 · 2015: 47 · 2014: 59 · 2013: 48 · 2012: 28
FWCI
4.17
Type
journal article
Language
en
Open access
Locations
  • Physical Therapy (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (UL1TR000448)
  • National Center for Research Resources (UL1RR024992)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
Keywords
diabetes epidemiology, diabetes complications, cardiovascular disease, diabetic nephropathy, diabetic neuropathy, diabetic retinopathy, lower limb amputation, economic burden of diabetes, diabetes prevention, intensive lifestyle intervention, glycemic control, blood pressure control, lipid control, diabetes prevalence projections, health disparities, diabetes risk factors
MeSH terms
Cardiovascular Diseases, Diabetes Mellitus, Diabetic Retinopathy, Humans, Risk Factors, United States, Incidence, Prevalence, Peripheral Vascular Diseases, Age Distribution, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review